Clinical Trials Logo

Clinical Trial Summary

Open label, multi-centre, Phase Ia/b adaptive design study with an initial 2-stage inter-participant Dose Escalation Phase followed by a Dose Expansion Phase.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06458712
Study type Interventional
Source Duke Street Bio Ltd
Contact Duke Street Bio
Phone +44 (0)203 890 8710
Email clinicaltrials@dukesb.com
Status Not yet recruiting
Phase Phase 1
Start date September 2024
Completion date August 2028